Bio-Rad Laboratories, Inc. (NYSE:BIO)
The Company manufactures and supplies the life science research, healthcare, analytical chemistry, and other markets with products and systems used to separate chemical and biological materials, and to identify analyze and purify their components.
- Quote
- Commentary
- Scorecard
- Historical Prices
- Chart
- Stats
- Ratios
- Earnings/Growth Rates
- Statements
- SEC Filings
Recs
This is one of my STARZ.
Here is the thought process on this STAR:
a) Divided rate over Zero
b) 3 Year Beta between -5 & +3
c) 15% + Insider ownership
d) No greater than -50% Growth rate for the last 3 years (tought= last couple of years so goo that insiders are still owning the stocks)
e) Current CAPS rating between 3 Stars & 5 Stars
Open to all Industries and Sectors screened this down to just 250 stocks. I like round numbers. 12 of them I already own through other screening tools. I tend to be somewhat conservative but looking for 3 things at this point in my investing:
1. Stability & Strength
2. Yield and Modest Growth
3. Strong Position within a sector regardless of whether the entire sector is strong or not. Each sector has to perform to some degree for the whole world economy to function. I am looking for 5 or more years down the road, ROI, and Growth.
Not looking for rockets, just stars. This is a Star!!
Recs
Stock screen - mid cap, 5 start CAPS, 5% + Ownership, P/E under 20
Recs
Adding to the Life Science Product Tracking List today. Have spent a good deal on online marketing lately, which should help boost sales against the big competitors. Curious to see how they fight it out with Life and the other large players though
Recs
They are gaining market share in one of the strongest industries. strong P/E, ROI, and price to FCF,
Recs
this is a great value stock
Recs
Great management with well balanced healthcare portfolio with a position in tools and diagnostics.
Recs
Healthcare need I say more
Recs
Health market preproducts companies such as Bio-Rad laboratories have a lot of growth potentail.
Recs
Recs
Headed North (or South?...) due to the
Recs
Value play as this stock has recently taken a beating dropping 19% in one month. It hasn't been this low since early October, 2006.
The future looks good for this company, and "buying" on the dip is a good play for BIO.
Recs
War on Terror
Recs
Why bet the field when you can play with the dealer
Recs
new products will give a good lift. i like this one. has consistently outperformed in the past, and i don't see that changing anytime soon
RSS Headlines
Fool UK
- Show Me:
-
Outperform
-
Underperform
-
All
- Sort by:
-
Author
-
Recs
-
Date
-
Member Rating
-
Results 1 - 14 of 14